1.Evaluation of bioceramic putty repairmen iRoot and mineral trioxide aggregate in mature permanent teeth pulpotomy.
Kun QIAN ; Jie PAN ; Wen Hao ZHU ; Xiao Yi ZHAO ; Chang LIU ; Wei YONG
Journal of Peking University(Health Sciences) 2022;54(1):113-118
OBJECTIVE:
To evaluate the clinical characteristics and effectiveness of pulpotomy in mature permanent teeth with bioceramic putty repairmen iRoot and mineral trioxide aggregate (MTA).
METHODS:
Pulpotomy was performed on mature permanent premolars and molars with carious exposures at the Department of General Dentistry of Peking University School and Hospital of Stomatology, from November 2017 to September 2019. The patients were randomly divided into 2 groups, Group iRoot (n=22) and Group MTA (n=21). In Group iRoot, bioceramic putty repairmen iRoot was used as pulp capping agent, while in Group MTA, mineral trioxide aggregate was used as pulp capping agent. All the patients had signed informed consent forms. The clinical efficacy was evaluated by clinical examinations (temperature and electrical activity test) and imaging examinations 3, 6, and 12 months after surgery. Blinding was used for the patients and evaluators, but due to the obvious differences in the properties of the two pulp capping agents, the blinding method was not used for the treatment provider (the attending physician).
RESULTS:
There was no significant difference in gender, average age, dentition and tooth position distribution between the two groups (P>0.05). In the study, 7 cases were lost to follow-up 12 months after operation (4 cases in Group iRoot, and 3 cases in Group MTA). One case in each of the two groups had transient sensitivity at the end of the 3-month follow-up, and the pulp vitality was normal at the end of the 6-month follow-up. One case in Group iRoot showed sensitivity at the end of the 12-month follow-up. The success rates of the two groups at the end of 12-month follow-up were 100%, and the cure rates were 94.4% (Group iRoot) and 100% (Group MTA), respectively, and the difference was not statistically significant (P>0.05). No cases in Group iRoot had obvious crown discoloration, while 3 cases in Group MTA had.
CONCLUSION
The clinical characteristics and effectiveness of pulpotomy in mature permanent teeth with bioceramic putty repairmen iRoot were similar with MTA. Bioceramic putty repairmen iRoot is an acceptable material when used in pulpotomy of mature permanent teeth. Because it is not easy to cause tooth discoloration after treatment and is convenient to operate, bioceramic putty repairmen iRoot has a better clinical application prospect.
Aluminum Compounds/therapeutic use*
;
Calcium Compounds/therapeutic use*
;
Drug Combinations
;
Humans
;
Oxides/therapeutic use*
;
Pulpotomy
;
Silicates/therapeutic use*
;
Treatment Outcome
2.Antibacterial Effectiveness of Calcium Hydroxide Combined with Cresotin against Enterococcus faecalis
Aprilia ; Belinda Kusuma ; Istien Wardani
Archives of Orofacial Sciences 2021;16(SUPP 1):11-15
ABSTRACT
The goal of endodontic treatment is to prevent and control of pulp and periradicular infections. Calcium
hydroxide has a beneficial biological property as an intracanal medicament and can be combined with
cresotin to disinfect bacteria in root canals, especially Enterococcus faecalis (E. faecalis) which is the
most frequently isolated strain in the root canals. The aim of this study was to investigate in vitro the
antimicrobial activity of calcium hydroxide, cresotin, and combination calcium hydroxide and cresotin
(Ca[OH]2+Cresotin, 1:1 and 1:2) against E. faecalis. Antibacterial activity was determined by the agar
diffusion method. The test medicaments were placed inside the hole that made in the inoculated agar
medium. The zone of growth inhibition was measured and recorded after incubation for each plate,
and the result was analysed statistically with ANOVA. The in vitro antimicrobial effects of combination
calcium hydroxide and cresotin (Ca[OH]2+Cresotin, 1:2) has more prominent antimicrobial activity
than others, and calcium hydroxide is more effective than cresotin alone. The antimicrobial activity of
combined calcium hydroxide and cresotin is more effective in killing E. faecalis in comparison to the other
treatments.
Calcium Hydroxide--therapeutic use
;
Root Canal Therapy
;
Enterococcus faecalis
3.Recent developments of researches on calcium phosphate cements.
Journal of Biomedical Engineering 2009;26(1):202-205
The research of calcium phosphate cement (CPC) has been developing for more than 20 years. In this review, we present a brief introduction to recent advances in researches on apatite CPC, brushite CPC, composite CPC materials; on factors affecting CPC capability and application; and on new application of CPC. The view that emphasizes the significance of studies on CPC with quicker degradation and osteoblast activity is put forward, particularly.
Absorbable Implants
;
Bone Cements
;
chemistry
;
therapeutic use
;
Bone Substitutes
;
chemistry
;
therapeutic use
;
Calcium Phosphates
;
chemistry
;
therapeutic use
;
Humans
6.New ideas for the diagnosis and treatment of Fanconi syndrome: a pilot study.
Shao-Fang TANG ; Hong-Tao LI ; Mei ZHU ; Zhong-Shu MA ; Ming-Cai QIU
Chinese Medical Journal 2013;126(17):3388-3390
7.Two-year outcomes of pulpotomy in primary molars using mineral trioxide aggregate: a retrospective study.
Gui Li DOU ; Nan WU ; Shuang Yun ZHAO ; Bin XIA
Journal of Peking University(Health Sciences) 2018;50(1):170-175
OBJECTIVE:
To evaluate the two-year outcomes of primary molars pulpotomy using mineral trioxided aggregate (MTA) and to find out the potential influence factor, with the help of electronic medical record database.
METHODS:
Children who received primary molars pulpotomy in the Department of Pediatric Dentistry in Peking University School and Hospital of Stomatology from May, 2014 to November, 2015 were searched in the Electronic Medical Record Database of Peking University School and Hospital of Stomatology, via the database for scientific research provided by the corporation of Kaientai. The children who were healthy, no more than 8 years old and followed up over 1.5 years were selected as the subjects of this study. At the same time, those children who didn't have complete medical records and X-rays before and after treatment were removed. Basic information, the relevant medical records and radiographic records of those children were collected. All molars were examined clinically and radiographically, and classified into 1 of 5 outcomes: N, H, P0, PX, PY. Molars classified into P0, PX and PY were regarded as failed. Survival analysis was applied. The survival rate and survival time of the deciduous teeth were calculated.Multivariate analysis was performed by using Cox proportional hazard model.
RESULTS:
One hundred and fifteen children were finally included,aged from 2.6 to 8.2 years, with the mean age of (4.5±1.1) years. 211 primary molars were included, and the average follow up time was (880±154) days. A good level of agreement between the raters was found for molars with five outcomes(κ=0.913). Intrarater reliability was good for molars with five outcomes (κ=0.916). Forty-nine molars failed by September, 2017. Forty-three molars had abnormal radiographic manifestation. Six molars suffered premature loss. Only fourteen molars had an associated gingival swelling or parulis, or pathologic mobility upon clinical examination. The cumulative survival probability of half a year, one year, one year and a half, two years, two year and a half for the pulpotomy was 100%, 98.5%, 92.9%, 90.5%,73.8% through the Kaplan-Meier method, respectively. Through the analysis of Cox proportional hazard model, the survival probability was significantly higher when the age was younger. When sodium hypochlorite and the saline were used as the irrigation at the same time, the survival probability was not improved for those teeth with more bleeding in the operation compared with that used saline only. The teeth with preformed metal crown (PMC) gained longer median survival time than those restored with resin composite and others, but the difference was not significant, either. What's more, gender, the restoration time of PMC, the restoration of the opposite teeth were not found to be associated with the success of the treatment.
CONCLUSION
The cumulative survival probability of two years after the primary pulpotomy was 90.5%, complying the current instructions in our department. The survival probability of the molars after the treatment was significantly affected by the age.
Aluminum Compounds/therapeutic use*
;
Calcium Compounds/therapeutic use*
;
Child
;
Drug Combinations
;
Humans
;
Molar
;
Oxides/therapeutic use*
;
Pulpotomy/methods*
;
Reproducibility of Results
;
Retrospective Studies
;
Silicates/therapeutic use*
;
Tooth, Deciduous
8.Analysis of clinical use of shuxuening injection in treatment of cerebral infarction based on real world.
Yan-Hua LUO ; Yan-Ming XIE ; Wei YANG ; Yong-Yan WANG ; Li YOU ; Yan ZHUANG
China Journal of Chinese Materia Medica 2014;39(18):3499-3503
To know the characteristics of Shuxuening injection used on cerebral infarction patients in clinical practice, 6 053 cases of Hospital information system (HIS) data from 20 hospitals were analyzed. Using the basic description method and association rules to analysis the data. By analysis the data we found that the average age of cerebral infarction patients who used Shuxuening injection is 67.96, 83.94% of patients were aged 46-80. The injection is administered intravenously,with most patients receiving a dosage of 15-20 mL per dose for between 1 and 14 days. It is always combined with aspirin (48.508%), cinepazide maleate injection (22.073%), atorvastatin calcium tablets (18.873%) in clinical practice. When it comes to two drug combinations, it always combined with cinepazide maleate injection and aspirin (8.178%), nicergoline capsules and aspirin (7.63%). Therefore, based on existing data, we give the conclusion that for the treatment of cerebral infarction Shuxuening injection is mainly used for older patients, and is often combination with similar pharmacological effects chemical drugs, which is complied with the guidelines. However, the wrong dose is still exist, doctors should realize the hiding risk.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Anticoagulants
;
therapeutic use
;
Aspirin
;
therapeutic use
;
Atorvastatin Calcium
;
Cerebral Infarction
;
drug therapy
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Heptanoic Acids
;
therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Piperazines
;
therapeutic use
;
Pyrroles
;
therapeutic use
;
Young Adult
9.Antihypertrophic effect of dihydropyridines calcium channel blockers is dependent on their potential of blocking N-type calcium channel.
Qiong LUO ; Wan-ling XUAN ; Fang XI ; Yu-lin LIAO ; Masafumi KITAKAZE
Journal of Southern Medical University 2010;30(4):755-759
OBJECTIVETo compare the effects of amlodipine, benidipine and nifedipine on myocardial hypertrophy and evaluate the underlying mechanism.
METHODSMyocardial hypertrophy model was created by transverse aortic constriction (TAC) in C57 BL/6 mice, and plasma catecholamine concentrations were measured 7 days after surgery to confirm the sympathetic activation. The 3 drugs were administered in TAC mice for 7 days and cardiac hypertrophy was evaluated according to the heart-to-body weight ratio (HW/BW). Effects of those drugs on the protein synthesis stimulated by phenylephrine in cultured neonatal cardiac myocytes were also examined.
RESULTSHW/BW and plasma concentrations of catecholamine were significantly increased in TAC mice one week after surgery in comparison with to sham-operated mice. One week after TAC, the HW/BW ratio was significantly lower in the amolodipine but not nifedipine-treated group than in the TAC group. Administration of nifedipine via minipump infusion for one week did not decrease HW/BW ratio. Treatment with amlodpine or benidipine, but not nifedipine, decreased the neonatal rat myocyte protein synthesis induced by phenylephrine stimulation.
CONCLUSIONAntihypertrophic effect of DHEs on myocardium is dependent on their potential of blocking N-type calcium channel, and the underlying mechanism involves the sympathetic inhibition.
Amlodipine ; pharmacology ; therapeutic use ; Animals ; Calcium Channel Blockers ; pharmacology ; therapeutic use ; Calcium Channels, N-Type ; drug effects ; Cardiomegaly ; drug therapy ; etiology ; Dihydropyridines ; pharmacology ; therapeutic use ; Disease Models, Animal ; Male ; Mice ; Mice, Inbred C57BL ; Nifedipine ; pharmacology ; therapeutic use